MosaMedix ATP: Annexin Technology Platform

ATP comprises a deep knowledge and expertise about Annexin A5, a 36 kD protein, and its structure/function relationship to bind selectively to cells executing cell death. MosaMedix ATP powers the generation of a wide range of diagnostic & therapeutic compounds combining the targeting function of annexin A5 with drugs or drug carriers or diagnostic agents. MosaMedix B.V. has filed patent applications for several engineered variants together with claims for potential diagnostic - and therapeutic uses in a wide range of serious medical conditions, such as cancers, cardiovascular- and autoimmune diseases.